1. Home
  2. BZAI vs SGHT Comparison

BZAI vs SGHT Comparison

Compare BZAI & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blaize Holdings Inc.

BZAI

Blaize Holdings Inc.

N/A

Current Price

$0.57

Market Cap

268.9M

Sector

N/A

ML Signal

N/A

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

N/A

Current Price

$8.16

Market Cap

309.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BZAI
SGHT
Founded
2010
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
268.9M
309.6M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
BZAI
SGHT
Price
$0.57
$8.16
Analyst Decision
Strong Buy
Buy
Analyst Count
3
7
Target Price
$4.67
$9.08
AVG Volume (30 Days)
7.1M
206.2K
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
43.43
28.16
EPS
N/A
N/A
Revenue
N/A
$77,363,000.00
Revenue This Year
$239.02
$11.67
Revenue Next Year
$45.85
$10.39
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.42
$3.19
52 Week High
$6.76
$9.24

Technical Indicators

Market Signals
Indicator
BZAI
SGHT
Relative Strength Index (RSI) 39.68 56.69
Support Level $0.42 $8.00
Resistance Level $0.54 $8.80
Average True Range (ATR) 0.04 0.35
MACD 0.02 -0.15
Stochastic Oscillator 82.22 29.36

Price Performance

Historical Comparison
BZAI
SGHT

About BZAI Blaize Holdings Inc.

Blaize Holdings Inc provides transformative artificial intelligence (AI)-enabled edge computing solutions comprised of both its proprietary hardware and software, and third-party hardware solutions. Its portfolio includes programmable AI processors in various form factors, which can be deployed across sectors such as smart cities, defense, retail, and enterprise markets. The company operates as a single operating and reportable segment. The majority of the company's revenue is derived from Hardware revenue, which includes the sale of its semiconductor products and/or third-party hardware products that support semiconductor products through various supply agreements. Geographically, it generates the maximum revenue from China.

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

Share on Social Networks: